Stand out for this role — generate a tailored resume and cover letter in about a minute.
Seaport Therapeutics in Boston is seeking a lab-based bioanalytical co-op focused on LC-MS to support the Discovery team's preclinical work. The successful candidate will work on in vitro screenings of lipid prodrugs and contribute to method development for quantitative and qualitative analyses.
The role offers exposure to a startup environment, collaboration with multidisciplinary scientists, and hands-on experience with chromatography, mass spectrometry, and data reporting while documenting
Seaport Therapeutics is a clinical-stagetherapeuticscompany advancing the development of novel neuropsychiatric medicines in areas of high unmet patient needs. The Company has a proven strategy of advancing clinically validated mechanisms previously held back by limitations that are overcome with its proprietaryGlyphTMtechnology platform. All the therapeutic candidates in its pipeline of first and best-in-class medicines are based on the Glyph platform, which is uniquely designed to enable oral bioavailability, bypass first-passmetabolismand reduce hepatotoxicity and other side effects. Seaport is led by an experienced team that invented and advanced important neuropsychiatric medicines and areguided by an extensive network of renowned scientists,cliniciansand key opinion leaders. For more information, please visitwww.seaporttx.com .
Job Description
Seaport Therapeutics is seeking a co-op student for a lab-based bioanalysis position to be part of our Discovery team. This co-op will have a focus on LC-MS to assist in the screening of novel drugs. We are looking for a highly motivated individual who is looking to be a part of a multidisciplinary team and to gain experience in a startup environment. This position will contribute to advancing the pipeline of impactful candidates generated from our novel Glyph™ prodrug platform.
Some of the responsibilities will include:
Experience and Skills